- Home
- FENC vs GPMT Comparison
FENC vs GPMT Comparison
Compare FENC & GPMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENC
- GPMT
- Stock Information
- Founded
- FENC 1996
- GPMT 2015
- Country
- FENC United States
- GPMT United States
- Employees
- FENC N/A
- GPMT N/A
- Industry
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- GPMT Real Estate Investment Trusts
- Sector
- FENC Health Care
- GPMT Real Estate
- Exchange
- FENC Nasdaq
- GPMT Nasdaq
- Market Cap
- FENC 172.8M
- GPMT 149.5M
- IPO Year
- FENC 2001
- GPMT 2017
- Fundamental
- Price
- FENC $6.07
- GPMT $3.21
- Analyst Decision
- FENC Strong Buy
- GPMT Buy
- Analyst Count
- FENC 2
- GPMT 4
- Target Price
- FENC $14.00
- GPMT $4.58
- AVG Volume (30 Days)
- FENC 173.1K
- GPMT 343.8K
- Earning Date
- FENC 11-07-2024
- GPMT 02-12-2025
- Dividend Yield
- FENC N/A
- GPMT 6.08%
- EPS Growth
- FENC N/A
- GPMT N/A
- EPS
- FENC N/A
- GPMT N/A
- Revenue
- FENC $49,348,000.00
- GPMT N/A
- Revenue This Year
- FENC $97.94
- GPMT N/A
- Revenue Next Year
- FENC $11.50
- GPMT N/A
- P/E Ratio
- FENC N/A
- GPMT N/A
- Revenue Growth
- FENC 278.09
- GPMT N/A
- 52 Week Low
- FENC $3.96
- GPMT $2.46
- 52 Week High
- FENC $11.92
- GPMT $6.41
- Technical
- Relative Strength Index (RSI)
- FENC 61.50
- GPMT 42.62
- Support Level
- FENC $5.77
- GPMT $3.28
- Resistance Level
- FENC $6.35
- GPMT $3.42
- Average True Range (ATR)
- FENC 0.39
- GPMT 0.12
- MACD
- FENC -0.02
- GPMT -0.03
- Stochastic Oscillator
- FENC 51.62
- GPMT 8.08
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About GPMT Granite Point Mortgage Trust Inc.
Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning, and repurposing of the property.